Mar 31, 2020
Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections
Mar 25, 2020
Ibuprofen (CAS 15687-27-1) Market Research Report 2020 - ResearchAndMarkets.com
Mar 20, 2020
Information Update - No scientific evidence that ibuprofen worsens COVID-19 symptoms
Mar 17, 2020
Caldolor® Demonstrates Favorable Safety Profile In Newborns
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Jan 07, 2020
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product
Jan 29, 2019
Tris Pharma, Inc. Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen
Dec 05, 2018
Tris Pharma Issues Voluntary Nationwide Recall of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen
Oct 31, 2018
Nurofen and Pain UK Mobilise 24 People, That Suffered From Body Pain, to Help Build a Pop-Up Body Garden in 24 Hours and Showcase What Can be Achieved When Not Held Back by Pain
Aug 06, 2018
NSAIDs to Treat Arthritic Canines Through 2028; Stem Cell Therapies to Invigorate Canine Arthritis Treatment Market
Oct 05, 2017
Ibuprofen Market 2017 Analysis, Company Profiles, Sales, Demands and Forecasts 2022
Aug 29, 2017
AAOMS issues opioid prescribing recommendations